Clearing up: examination guidelines for pharma patents
Editha R. Hechanova and Fe Belen Bello
On the right track: the INPI ups its game
Brazil patent examination: Defying the backlog
Patenting drugs in Mexico: innovative or generics?
Questions of discovery and efficacy are pivotal in patenting new products, as Editha Hechanova and Fe Belen Bello explain.
On February 15, 2012, the Intellectual Property Offce of the Philippines (IPPHL) published on its website its Examination Guidelines for Pharmaceutical Patent Applications Involving Known Substances.
These guidelines were issued pursuant to the amendments in the patent law and its implementing rules and regulations, brought about by Republic Act No. 9502, the Universally Accessible Cheaper and Quality Medicines Act of 2008 (QUAMA).
The aim of this act is to promote and ensure access to affordable quality drugs and medicines for all, pursuant to the state's policy of protecting public health.
efficacy, pharmaceuticals, QUAMA, patent applications